Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* onset of respiratory symptoms \>12 days prior to randomization * intubated or plan in place for intubation * plasma is contraindicated (e.g. history of anaphylaxis from transfusion) * decision in place for no active treatment	* onset of respiratory symptoms \>12 days prior to randomization * intubated or plan in place for intubation * plasma is contraindicated (e.g. history of anaphylaxis from transfusion) * decision in place for no active treatment
Nov. 2, 2021, 12:30 p.m.	usa	- onset of respiratory symptoms >12 days prior to randomization - intubated or plan in place for intubation - plasma is contraindicated (e.g. history of anaphylaxis from transfusion) - decision in place for no active treatment	- onset of respiratory symptoms >12 days prior to randomization - intubated or plan in place for intubation - plasma is contraindicated (e.g. history of anaphylaxis from transfusion) - decision in place for no active treatment
Oct. 26, 2020, 11:31 p.m.	usa	- onset of symptoms >12 days prior to randomization - intubated or plan in place for intubation - plasma is contraindicated (e.g. history of anaphylaxis from transfusion) - decision in place for no active treatment	- onset of symptoms >12 days prior to randomization - intubated or plan in place for intubation - plasma is contraindicated (e.g. history of anaphylaxis from transfusion) - decision in place for no active treatment